ID   NSMA_HUMAN              Reviewed;         423 AA.
AC   O60906; Q5TED1; Q9BWR3;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   12-APR-2017, entry version 149.
DE   RecName: Full=Sphingomyelin phosphodiesterase 2;
DE            EC=3.1.4.12;
DE   AltName: Full=Lyso-platelet-activating factor-phospholipase C;
DE            Short=Lyso-PAF-PLC;
DE   AltName: Full=Neutral sphingomyelinase;
DE            Short=N-SMase;
DE            Short=nSMase;
GN   Name=SMPD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, TISSUE SPECIFICITY, AND
RP   VARIANTS LEU-3 AND SER-265.
RX   PubMed=9520418; DOI=10.1073/pnas.95.7.3638;
RA   Tomiuk S., Hofmann K., Nix M., Zumbansen M., Stoffel W.;
RT   "Cloned mammalian neutral sphingomyelinase: functions in sphingolipid
RT   signaling?";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3638-3643(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-265.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   CHARACTERIZATION.
RX   PubMed=10608884; DOI=10.1074/jbc.274.53.38131;
RA   Sawai H., Domae N., Nagan N., Hannun Y.A.;
RT   "Function of the cloned putative neutral sphingomyelinase as lyso-
RT   platelet activating factor-phospholipase C.";
RL   J. Biol. Chem. 274:38131-38139(1999).
CC   -!- FUNCTION: Converts sphingomyelin to ceramide. Hydrolyze 1-acyl-2-
CC       lyso-sn-glycero-3-phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso-
CC       sn-glycero-3-phosphocholine (lyso-platelet-activating factor). The
CC       physiological substrate seems to be Lyso-PAF.
CC   -!- CATALYTIC ACTIVITY: Sphingomyelin + H(2)O = N-acylsphingosine +
CC       phosphocholine.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.5-7.5.;
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the neutral sphingomyelinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ222801; CAA10995.1; -; mRNA.
DR   EMBL; AL109947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000038; AAH00038.1; -; mRNA.
DR   CCDS; CCDS5075.1; -.
DR   RefSeq; NP_003071.2; NM_003080.2.
DR   UniGene; Hs.55235; -.
DR   ProteinModelPortal; O60906; -.
DR   BioGrid; 112494; 21.
DR   IntAct; O60906; 8.
DR   STRING; 9606.ENSP00000258052; -.
DR   BindingDB; O60906; -.
DR   ChEMBL; CHEMBL4712; -.
DR   SwissLipids; SLP:000000174; -.
DR   iPTMnet; O60906; -.
DR   PhosphoSitePlus; O60906; -.
DR   BioMuta; SMPD2; -.
DR   EPD; O60906; -.
DR   MaxQB; O60906; -.
DR   PaxDb; O60906; -.
DR   PeptideAtlas; O60906; -.
DR   PRIDE; O60906; -.
DR   DNASU; 6610; -.
DR   Ensembl; ENST00000258052; ENSP00000258052; ENSG00000135587.
DR   GeneID; 6610; -.
DR   KEGG; hsa:6610; -.
DR   UCSC; uc003pti.4; human.
DR   CTD; 6610; -.
DR   DisGeNET; 6610; -.
DR   GeneCards; SMPD2; -.
DR   H-InvDB; HIX0006125; -.
DR   HGNC; HGNC:11121; SMPD2.
DR   HPA; HPA018110; -.
DR   HPA; HPA018125; -.
DR   MIM; 603498; gene.
DR   neXtProt; NX_O60906; -.
DR   OpenTargets; ENSG00000135587; -.
DR   PharmGKB; PA35970; -.
DR   eggNOG; KOG3873; Eukaryota.
DR   eggNOG; ENOG410ZFPY; LUCA.
DR   GeneTree; ENSGT00390000009166; -.
DR   HOGENOM; HOG000044683; -.
DR   HOVERGEN; HBG019089; -.
DR   InParanoid; O60906; -.
DR   KO; K12351; -.
DR   OMA; QARWWAT; -.
DR   OrthoDB; EOG091G0EZ8; -.
DR   PhylomeDB; O60906; -.
DR   TreeFam; TF313899; -.
DR   BRENDA; 3.1.4.12; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-HSA-193681; Ceramide signalling.
DR   Reactome; R-HSA-5626978; TNFR1-mediated ceramide production.
DR   UniPathway; UPA00222; -.
DR   GeneWiki; SMPD2; -.
DR   GenomeRNAi; 6610; -.
DR   PRO; PR:O60906; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000135587; -.
DR   CleanEx; HS_SMPD2; -.
DR   ExpressionAtlas; O60906; baseline and differential.
DR   Genevisible; O60906; HS.
DR   GO; GO:0005901; C:caveola; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004767; F:sphingomyelin phosphodiesterase activity; TAS:ProtInc.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:2000304; P:positive regulation of ceramide biosynthetic process; TAS:Reactome.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0006684; P:sphingomyelin metabolic process; TAS:ProtInc.
DR   Gene3D; 3.60.10.10; -; 1.
DR   InterPro; IPR005135; Endo/exonuclease/phosphatase.
DR   Pfam; PF03372; Exo_endo_phos; 1.
DR   SUPFAM; SSF56219; SSF56219; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Hydrolase; Lipid metabolism; Magnesium; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome;
KW   Sphingolipid metabolism; Transmembrane; Transmembrane helix.
FT   CHAIN         1    423       Sphingomyelin phosphodiesterase 2.
FT                                /FTId=PRO_0000075686.
FT   TRANSMEM    330    350       Helical. {ECO:0000255}.
FT   TRANSMEM    354    374       Helical. {ECO:0000255}.
FT   ACT_SITE    272    272       Proton acceptor. {ECO:0000250}.
FT   METAL        49     49       Magnesium. {ECO:0000250}.
FT   SITE        180    180       Important for substrate recognition.
FT                                {ECO:0000250}.
FT   VARIANT       3      3       P -> L (in dbSNP:rs1048197).
FT                                {ECO:0000269|PubMed:9520418}.
FT                                /FTId=VAR_050305.
FT   VARIANT     223    223       V -> I (in dbSNP:rs9386806).
FT                                /FTId=VAR_050306.
FT   VARIANT     265    265       R -> S (in dbSNP:rs1476387).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9520418}.
FT                                /FTId=VAR_024181.
SQ   SEQUENCE   423 AA;  47646 MW;  3C1514CE21560501 CRC64;
     MKPNFSLRLR IFNLNCWGIP YLSKHRADRM RRLGDFLNQE SFDLALLEEV WSEQDFQYLR
     QKLSPTYPAA HHFRSGIIGS GLCVFSKHPI QELTQHIYTL NGYPYMIHHG DWFSGKAVGL
     LVLHLSGMVL NAYVTHLHAE YNRQKDIYLA HRVAQAWELA QFIHHTSKKA DVVLLCGDLN
     MHPEDLGCCL LKEWTGLHDA YLETRDFKGS EEGNTMVPKN CYVSQQELKP FPFGVRIDYV
     LYKAVSGFYI SCKSFETTTG FDPHRGTPLS DHEALMATLF VRHSPPQQNP SSTHGPAERS
     PLMCVLKEAW TELGLGMAQA RWWATFASYV IGLGLLLLAL LCVLAAGGGA GEAAILLWTP
     SVGLVLWAGA FYLFHVQEVN GLYRAQAELQ HVLGRAREAQ DLGPEPQPAL LLGQQEGDRT
     KEQ
//
